DIRS.INFO The most relevant business & tech news

☆ Exclusive: EU may pay more for Pfizer COVID shots in return for lower volume
▼ + stars: | 2023-01-27 | by ( Maggie Fick | ) www.reuters.com time to read: +5 min

A Pfizer spokesperson declined to comment on details of the discussions, but said the company has shown ongoing commitment to accommodating EU member state concerns. Most people in the EU who wanted a primary course of the COVID-19 vaccine, and those who were later eligible for boosters, have received them. In May 2021, Brussels signed a contract with Pfizer and BioNTech to buy 900 million doses, with an option for an additional 900 million doses, by the end of 2023. Around half or more of the first 900 million doses from that contract have not yet been delivered because demand dropped last year. That came after EU governments warned Pfizer and other companies that millions of doses could go to waste.

☆ Nokia's quarterly profit beats expectations on 'robust' demand
▼ + stars: | 2023-01-26 | by ( ) www.reuters.com time to read: +1 min

STOCKHOLM, Jan 26 (Reuters) - Nokia (NOKIA.HE) on Thursday beat quarterly operating profit expectations and forecast higher 2023 sales as the Finnish telecom equipment maker benefited from 5G roll-out in countries such as India. "Looking forward to 2023, while we are mindful of the uncertain economic outlook, demand remains robust," Lundmark said in a statement. Nokia forecast full-year net sales of between 24.9 billion euros and 26.5 billion euros, which implies between 2% and 8% growth in constant currency. Analysts expect 25.5 billion euros. Net sales grew 16% to 7.45 billion euros, beating estimates of 7.11 billion.

☆ Europe Inc earnings offer market optimists more hope
▼ + stars: | 2023-01-25 | by ( ) www.reuters.com time to read: +5 min

Shares in ASML were lower after the results, having rallied recently to hit their highest since last April. Helped by strong orders in Europe, French train maker Alstom (ALSO.PA) posted an 8% rise in third-quarter sales. While it is still early in the corporate earnings season, the results offer some hope that recent economic data which has buoyed equities this month is grounded in reality. Swiss asset manager GAM (GAMH.S) meanwhile warned on profits after experiencing negative asset flows, knocking its shares 2.5% lower in early morning trading. ($1 = 0.8115 pounds)Reporting by Reuters newsroom; Writing by Josephine Mason; Editing by Catherine EvansOur Standards: The Thomson Reuters Trust Principles.

☆ Tank maker Rheinmetall raises sales view as Ukraine war boosts demand
▼ + stars: | 2023-01-24 | by ( ) www.reuters.com time to read: +3 min

Shares in Rheinmetall, which together with Krauss-Maffei Wegmann makes the Leopard tanks Germany is under pressure from Kyiv and some allies to send to Ukraine, have risen 170% in the past year. For 2022 the company expects sales of 6.5 billion euros. A company spokesperson told media group RND that it could deliver 139 Leopard tanks to Ukraine if needed. It could also supply 88 older Leopard 1 tanks, the spokesperson said, without giving a timeframe for potential delivery. It said positives, including mid-term defence spending, had been priced into the stock.

☆ Analysis: Europe Inc earnings season a test for market optimism
▼ + stars: | 2023-01-23 | by ( Joice Alves | ) www.reuters.com time to read: +4 min

In a sign analysts were unprepared for such optimism, Citi's economic surprise indicator for the euro zone (.CESIEUR) jumped last week to its highest since July 2021. "Companies are telling us that it's going to be harder to pass on rising costs to customers in 2023 as economic growth slows," said Nigel Bolton, co-chief investment officer of BlackRock Fundamental Equities. Fourth-quarter earnings for STOXX 600 companies are forecast to have grown by 10.7% year-on-year, the slowest in two years, according to Refinitiv I/B/E/S data. Earnings are seen bouncing back to growth of 11.4% in the final quarter of the year. Analysts downgrade earnings forecastsReporting by Joice Alves Editing by Josephine Mason and Mark PotterOur Standards: The Thomson Reuters Trust Principles.

[1/2] FILE PHOTO-Planes of German air carrier Lufthansa are parked as Lufthansa pilots start a strike over a wage dispute, at the airport in Frankfurt, Germany, September 2, 2022. REUTERS/Kai PfaffenbachROME/FRANKFURT, Jan 18 (Reuters) - German carrier Lufthansa (LHAG.DE) said on Wednesday it had offered to buy an minority stake in ITA Airways, betting on reviving the loss-making successor to Italy's Alitalia and expanding its footprint in Europe. One of the sources said it was valued at 200-300 million euros ($540 million). The new right-wing administration in Rome passed a decree in December to initially sell a minority stake through capital increases, in order to speed up a full divestment in ITA. "Acquiring ITA is one of the most challenging propositions in European aviation: the airline has been persistently loss-making," said Bernstein analyst Alex Irving.

☆ Davos 2023: Moderna CEO in talks with China to supply COVID vaccines
▼ + stars: | 2023-01-18 | by ( Brenda Goh | ) www.reuters.com time to read: +2 min

DAVOS, Switzerland, Jan 18 (Reuters) - Moderna (MRNA.O) chief executive Stephane Bancel said on Wednesday the U.S. company was in active discussions to supply COVID-19 vaccines to China. Beijing has so far insisted on using only Chinese-made COVID-19 vaccines for its own population, but the country is beset by a raging COVID outbreak following a U-turn from Beijing on previously ultra-tight anti-pandemic curbs. China-made COVID vaccines are of the inactivated virus type and not based on the messenger RNA technology used in the most widely used shots developed by Moderna and Pfizer (PFE.N)-BioNTech (22UAy.DE). As regards cancer treatments, Moderna has been working with Merck (MRK.N) on an experimental vaccine against melanoma based on the mRNA technology used in successful COVID-19 vaccines. The company, whose COVID-19 vaccines are made in the United States and Switzerland, is building or planning to build plants in Canada, Australia, Britain and Kenya, he said.

LONDON/ZURICH, Jan 18 (Reuters) - Luxury retailers Richemont (CFR.S) and Burberry (BRBY.L) said they were optimistic that consumers in China would start spending again, helping offset three years of upheaval from the government's strict COVID-19 lockdowns and soaring infections. Richemont (CFR.S), whose brands include Cartier jewellery and Swiss watches IWC and Jaeger-LeCoultre, also said it expected a strong rebound in China. The European luxury sector is among the largest expected winners as China loosens COVID-19 restrictions that kept shoppers out of stores for months. Richemont missed market estimates after sales in China plunged by a quarter, as customer traffic dwindled and staff were not available, leading to a reduction of boutique hours, or temporary closures of sales points, the company said. Mainland China is currently 25% of Burberry sales, down from about 40% pre-pandemic.

☆ Davos 2023: Moderna CEO says he wants to have mRNA factory on every continent
▼ + stars: | 2023-01-18 | by ( ) www.reuters.com time to read: 1 min

Companies Moderna Inc FollowDAVOS, Switzerland, Jan 18 (Reuters) - Moderna (MRNA.O) chief executive Stephane Bancel said he would like to have factories making vaccines based on its messenger RNA technology on every continent as the U.S. company prepares to build four facilities. "We're talking to a couple more countries because I would really like on every continent to have MRNA capacity," he said on a panel at the World Economic Forum annual meeting in Davos. The company is building or planning to build factories in Canada, Australia, Britain and Kenya, he said. Its COVID-19 vaccines are made in the United States and Switzerland. For daily Davos updates in your inbox sign up for the Reuters Daily Briefing hereReporting by Josephine Mason and Natalie Grover; Editing by Alexander SmithOur Standards: The Thomson Reuters Trust Principles.

☆ Analysis: UK housebuilders may cut dividends as surging rates deter buyers
▼ + stars: | 2023-01-09 | by ( Ajose Koilparambil | ) www.reuters.com time to read: +5 min

The big, listed UK housebuilders have paid dividends worth 2.2 billion pounds ($2.6 billion) for their respective last financial years. Potential cuts in dividends would weigh down on shares of housebuilders, after the sector index (.FTNMX402020) slumped more than 44% in 2022. Among the FTSE 100 builders, analysts are now forecasting dividend cuts from many firms, particularly those whose payouts are linked to earnings growth. High-end housebuilder Berkeley (BKGH.L) stuck to its cash-return plans, but cut its earnings estimates for the 2024 and 2025 fiscal years. Barratt, Persimmon and Berkeley have said they would be more cautious with land purchases, in a bid to reduce outgoings as falling property prices squeeze margins.

That might ease some concerns about the outbreak since Beijing abruptly reversed its "zero COVID" policy last month. But many Chinese funeral homes and hospitals say they are overwhelmed, and international health experts predict at least 1 million COVID-related deaths in China this year without urgent action. But the WHO said there is "no inevitability" in terms of predictions of large numbers of deaths. "It really does depend on the measures that are in place," said the WHO's COVID-19 technical lead Maria van Kerkhove. She said the WHO was working with China to improve access to life-saving tools and cope with health workforce issues in badly-hit areas.

☆ Leading WHO advisers call for 'realistic' COVID data from China at key meeting
▼ + stars: | 2023-01-03 | by ( Jennifer Rigby | ) www.reuters.com time to read: +3 min

[1/2] The World Health Organization logo is pictured at the entrance of the WHO building, in Geneva, Switzerland, December 20, 2021. REUTERS/Denis BalibouseLONDON, Jan 3 (Reuters) - Leading scientists advising the World Health Organization said they wanted a "more realistic picture" about the COVID-19 situation from China's top experts at a key meeting on Tuesday as worries grow about the rapid spread of the virus. The WHO has invited Chinese scientists to a virtual closed meeting with its technical advisory group on viral evolution on Tuesday, to present data on which variants are circulating in the country. Speaking to Reuters ahead of the meeting, she said some of the data from China, such as hospitalisation numbers, is "not very credible". A WHO spokesperson said that a "detailed discussion" was expected about circulating variants in China, and globally, with Chinese scientists expected to make a presentation.

"I can confirm a shipment of the BioNTech vaccine is on its way to China," the person told journalists in Berlin. In return, Chinese citizens in Europe can be vaccinated with China's SinoVac (SVA.O), the spokesperson said. Experts predict that the country of 1.4 billion people could face more than a million COVID deaths next year. China is stuck between rising Covid-19 cases and stalled vaccination ratesNO WESTERN SHOTSChina has nine domestically developed COVID vaccines approved for use, more than any other country. While the shots became available in Hong Kong, Macau and Taiwan, the regulatory review for mainland China has not been concluded.

Dec 21 (Reuters) - China may be struggling to keep a tally of COVID-19 infections as the country experiences a big spike in cases, a senior World Health Organization official said on Wednesday, amid concerns about a lack of data from the country. "In China, what's been reported is relatively low numbers of cases in ICUs, but anecdotally ICUs are filling up," WHO's emergencies director Mike Ryan said. "I wouldn't like to say that China is actively not telling us what's going on. REUTERS/Denis BalibouseThe WHO said it was ready to work with China to improve the way the country collects data around critical factors such as hospitalisation and death. China has nine domestically developed COVID-19 vaccines approved for use, more than any other country, but they have not been updated to target the highly infectious Omicron variant.

☆ Medical device makers drop products as EU law sows chaos
▼ + stars: | 2022-12-19 | by ( Maggie Fick | ) www.reuters.com time to read: +9 min

LONDON, Dec 19 (Reuters) - Nicola Osypka's German company has been selling medical devices used in surgery on newborn babies in Europe for decades, but new European Union rules have forced her to make tough decisions. While some companies say the products they have cut have no impact on patients or profits, others say some of withdrawn devices are essential, and doctors agree. Under the EU's Medical Devices Regulation (MDR), which came into effect in May 2021, all medical devices, from implants and prosthetics to blood glucose meters and catheters, must meet stricter safety criteria, sometimes with new clinical trials. Under the old system, it took about 15,000 euros and a few months to get a similar device approved, he said. Tom Melvin, an associate professor of medical device regulatory affairs at Trinity College Dublin, said there were nearly 100 such agencies a decade ago under the old system.

☆ China's COVID spike not due to lifting of restrictions, WHO director says
▼ + stars: | 2022-12-14 | by ( Emma Farge | ) www.reuters.com time to read: +3 min

The comments by the WHO's emergencies director Mike Ryan came as he warned of the need to ramp up vaccinations in the world's No. Speaking at a briefing with media, he said the virus was spreading "intensively" in the nation long before the lifting of restrictions. "There's a narrative at the moment that China lifted the restrictions and all of a sudden the disease is out of control," he said. "The disease was spreading intensively because I believe the control measures in themselves were not stopping the disease. Beijing started pivoting away from its signature "zero-COVID" policy this month after protests against the economically damaging curbs championed by President Xi Jinping.

☆ Exclusive: Chinese grab Russian car market share after Western rivals depart
▼ + stars: | 2022-12-08 | by ( Gleb Stolyarov | ) www.reuters.com time to read: +3 min

Reuters GraphicsRussia's new passenger car and LCV sales were 46,403 in November, the Association of European Businesses (AEB) said on Tuesday, and sales should reach around 600,000 for this year overall. "There is little production of Western car brands and few imports, so the market is divided between the Russian and Chinese car industries," Russian automotive analyst Vladimir Bespalov told Reuters. Russian cars satisfy demand at lower prices - up to about 1.5 million roubles ($23,961), and Chinese are also taking over the Western niche of prices above 2.5 million roubles. In one high-profile case, a Chinese car is masquerading as Russian one. In monetary terms, the share could surpass 40% of what he expects will be a 1.5-trillion-rouble market in 2023.

☆ Exclusive: EU to propose delay to medical device law amid supply worries
▼ + stars: | 2022-12-08 | by ( Maggie Fick | ) www.reuters.com time to read: +3 min

"Our patients expect that medical devices are safe and of highest quality. A Commission source said the extension will require an amendment to the law. Under the new law, all medical devices, from implants and prosthetics to blood glucose meters and pacemakers sold in the EU must be re-certified by May 2024. We are already seeing shortages of some essential medical devices, and in many cases alternative devices are missing," Christiaan Keijzer, president of the Standing Committee of European Doctors (CPME), told Reuters. The Commission said there are about 23,000 certificates under the old system which will expire by May 2024 without an extension.

South Africa, Pakistan and India were among countries that made formal requests, during an initial three days of talks that ended on Wednesday, to ensure the process is inclusive. "The advanced countries have the requisite resources and can afford to have it covered and we cannot," he said. In parallel, country teams are discussing setting up a G20 pandemic fund and revamping the WHO's existing health emergency rules. Many poorer countries lack technical specialists to advise on WHO matters within the Geneva diplomatic mission, where the U.N. agency is based. South Africa's Precious Matsoso, co-chair of the pandemic treaty talks, told Reuters countries could hire experts to help, or band together for regional representation.

☆ Pfizer to invest more than $2.5 bln to expand European manufacturing
▼ + stars: | 2022-12-02 | by ( Michael Erman | ) www.reuters.com time to read: +4 min

The Puurs site has played a key role in the production of COVID-19 vaccine shots Pfizer developed with its German partner BioNTech (22UAy.DE) using the messenger RNA (mRNA) technology. Output started there in late 2020 when Europe and the United States began rolling out shots to tackle the pandemic. "It is all aligned with the growth of our pipeline," Pfizer Chief Global Supply Officer Mike McDermott told Reuters. Pfizer has also been spending significantly to expand its manufacturing capacity in the United States. The New York-based drugmaker has announced plans to expand its Kalamazoo, Michigan, Rocky Mount, North Carolina, and McPherson, Kansas plants.

☆ Drop in COVID alertness could create deadly new variant - WHO
▼ + stars: | 2022-12-02 | by ( Bhanvi Satija | ) www.reuters.com time to read: +2 min

Dec 2 (Reuters) - Lapses in strategies to tackle COVID-19 this year continue to create the perfect conditions for a deadly new variant to emerge, as parts of China witness a rise in infections, the head of the World Health Organization said on Friday. BAY ISMOYO/Pool via REUTERS 1 2"Gaps in testing ... and vaccination are continuing to create the perfect conditions for a new variant of concern to emerge that could cause significant mortality," Tedros said. COVID-19 infections are at record highs in China and have started to rise in parts of Britain after months of decline. Further easing of COVID-19 testing requirements and quarantine rules in some Chinese cities was met with a mix of relief and worry on Friday, as hundreds of millions await an expected shift in national virus policies after widespread social unrest. The WHO urged governments globally to focus on reaching those at risk, such as people over the age of 60 and those with underlying conditions, for vaccination.

[1/2] Christel Heydemann, CEO of Orange, attends the MEDEF union summer forum "La Rencontre des Entrepreneurs de France, LaREF" at the Paris Longchamp Racecourse in Paris, France, August 30, 2022. 1 telecoms operator Orange (ORAN.PA) said on Wednesday, as the prospect of energy rationing looms amid the war in Ukraine. Executives said at the time there were not enough back-up systems in many European countries to handle widespread power cuts. "The operators put pressure so that we don't cut their antennas, there's a kind of arm wrestling," the source told Reuters. Only a few thousands mobile antennas would be completely shielded from potential power cuts at this stage, a telecoms industry source said, thus covering a fraction of the population and of the territory.

☆ Analysis: Out of fashion: Gucci faces daunting task to replace top designer
▼ + stars: | 2022-11-25 | by ( Mimosa Spencer | ) www.reuters.com time to read: +5 min

[1/4] Gucci's designer Alessandro Michele arrives at the "Green carpet Fashion Awards" event during the Milan Fashion Week in Milan, Italy, September 24, 2017. Tensions had been high between the designer and company management, sources told Reuters. Kering chairman and CEO François-Henri Pinault lauded the designer's tenure as "an outstanding moment" in Gucci's history. Gucci falls out of fashionFURRY LOAFERSMichele, 49, reinvigorated the brand with his eccentric, gender-fluid styles popular with younger shoppers. China generates around 35% of Gucci's annual sales, according to Barclays estimates, compared to 27% for LVMH's fashion and leather goods division and 26% for Hermes.

☆ Don't like Musk? Work for us! Tech firms woo ex-Twitter staff
▼ + stars: | 2022-11-22 | by ( Martin Coulter | ) www.reuters.com time to read: +3 min

That's the pitch being used by talent-starved technology firms trying to lure thousands of former Twitter Inc employees laid off by the social media company under its new owner. Twitter has fired top executives and enforced steep job cuts with little warning following Musk's tumultuous takeover of the social media platform. Other big U.S. tech firms including Meta (META.O) and Amazon (AMZN.O) have also laid off thousands of staff in recent weeks due to the uncertain economic environment. But the public criticism of Musk highlights strong demand in parts of the industry for highly skilled digital workers. Mass job cuts and public resignations at Twitter have prompted worries the firm is shedding vital staff and fears the social media "town square" could face technical troubles.

He will replace Bob Chapek, who took over as Disney CEO in February 2020 just as the COVID-19 pandemic hit, leading to park closures and restrictions on visitors globally. Disney disappointed investors this month with an earnings report that showed mounting losses at its streaming media unit that includes Disney+. [1/2] Executive Chairman of the Walt Disney Company, Bob Iger arrives at the world premiere for the film 'The King's Man' at Leicester Square in London, Britain December 6, 2021. IGER'S RETURNSIger exited Disney on a high note as the company led the battle against Netflix in the streaming wars. During his tenure, Disney made several key acquisitions, including Pixar Animation Studios, Marvel Entertainment and 21st Century Fox, and boosted its market capitalization five-fold.

Search resuls for: "Josephine Mason"

25 mentions found